Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0O7HD
|
|||
| Former ID |
DNC000401
|
|||
| Drug Name |
CEP1349
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Mixed lineage kinase 3 (MAP3K11) | Target Info | Inhibitor | [1] |
| KEGG Pathway | MAPK signaling pathway | |||
| Non-alcoholic fatty liver disease (NAFLD) | ||||
| Panther Pathway | CCKR signaling map ST | |||
| Pathway Interaction Database | Reelin signaling pathway | |||
| CDC42 signaling events | ||||
| IFN-gamma pathway | ||||
| RAC1 signaling pathway | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci. 2002 Jan;23(1):40-5. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.